SCHEMBL21589060

SCHEMBL21589060

c1ccc(CSc2c(-c3ccccc3)cc3ccccn23)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.48
L3MBTL1 Q9Y468 4/20 0.48
RAB9A P51151 3/20 0.48
NPC1 O15118 2/20 0.48
HTT P42858 3/20 0.44
THRB P10828 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 4/20 0.37
TDP1 Q9NUW8 3/20 0.37
MEN1 O00255 1/20 0.37
RECQL P46063 1/20 0.37
KMT2A Q03164 1/20 0.37
HPGD P15428 2/20 0.36
GAA P10253 1/20 0.36
ALOX12 P18054 1/20 0.36
KDM4E B2RXH2 2/20 0.35
CHEK1 O14757 1/20 0.35
LIMK1 P53667 1/20 0.35
MAPK14 Q16539 1/20 0.35
EGFR P00533 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21589235 0.83 MAPT (0.49) MAPTL3MBTL1RAB9ANPC1HTT
SCHEMBL8204958 0.73 MAPT (0.55) MAPTL3MBTL1RAB9ANPC1HTT
SCHEMBL21589175 0.71 MAPT (0.46) MAPTL3MBTL1RAB9ANPC1HTT
SCHEMBL9187424 0.70 MAPT (0.59) MAPTL3MBTL1RAB9ANPC1HTT
Iodide SCHEMBL10843424 0.68 MAPT (0.57) MAPTL3MBTL1RAB9ANPC1HTT
SCHEMBL16363728 0.68 MAPT (0.57) MAPTL3MBTL1RAB9ANPC1HTT
SCHEMBL1435606 0.68 MAPT (0.57) MAPTL3MBTL1RAB9ANPC1HTT
SCHEMBL8205262 0.68 MAPT (0.57) MAPTL3MBTL1RAB9ANPC1HTT
SCHEMBL10604301 0.65 MAPT (0.57) MAPTL3MBTL1RAB9ANPC1HTT
SCHEMBL27953291 0.65 MAPT (0.41) MAPTL3MBTL1RAB9ANPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019232665-A1 THIOLIZED INDOLIZINE COMPOUND HAVING ANTICANCER ACTIVITY AND DERIVATIVE THEREOF 广东药科大学 (CN) 2019-12-12 WO disclosed